Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
48 巻, 19 号
選択された号の論文の15件中1~15を表示しています
ORIGINAL ARTICLES
  • Hiroshi Yasuda, Masaya Yamada, Susumu Sawada, Yutaka Endo, Kazuaki Ino ...
    2009 年 48 巻 19 号 p. 1725-1730
    発行日: 2009年
    公開日: 2009/10/01
    ジャーナル オープンアクセス
    Objective We investigated the risk of upper gastrointestinal (UGI) bleeding and the protective effect of concomitant anti-secretory drugs during dual antiplatelet therapy administered following implantation of drug-eluting stents (DES) for coronary heart disease. Because proton pump inhibitors (PPIs) are reported to decrease the platelet inhibitory effects of clopidogrel, we also assessed cardiovascular outcomes in patients taking thienopyridine derivatives with or without anti-secretory drug.
    Methods We retrospectively analyzed 243 patients, who underwent DES implantation between January 2006 and December 2007 and were receiving dual anti-platelet therapy post-surgery. The main outcome measurement was the presence of UGI bleeding. Cardiovascular outcomes were assessed by follow-up coronary angiography (CAG) findings. Data were collected from medical records.
    Results Eight cases of UGI bleeding were observed during the follow-up period, none of whom were taking anti-secretory drugs. Among the 243 cases, 108 cases were taking anti-secretory drugs: a PPI (67 cases), and an H2 receptor antagonist (41 cases). No UGI bleeding was observed among patients who were taking concomitant anti-secretory drugs. The 1- and 2-year cumulative incidences of UGI bleeding among patients who were not taking anti-secretory drugs were 4.5% and 9.2%, respectively. When CAG findings were compared between patients not taking any anti-secretory drug, taking PPI, or taking H2RA, significantly more stenotic lesions of the coronary artery were observed in the PPI-treatment group.
    Conclusion Concomitant use of an anti-secretory agent was associated with a reduced risk of UGI bleeding. Use of PPI may be associated with an attenuation of the effect of dual antiplatelet therapy.
  • Yusuke Fukuda, Shin-ichiro Miura, Bo Zhang, Atsushi Iwata, Akira Kawam ...
    2009 年 48 巻 19 号 p. 1731-1737
    発行日: 2009年
    公開日: 2009/10/01
    ジャーナル オープンアクセス
    Objectives We investigated the significance of urinary liver fatty acid-binding protein (U-L-FABP) monitoring during cardiac catheterization in patients with cardiovascular disease (CVD).
    Methods The subjects included 27 consecutive patients with stable angina (SAP group) or acute coronary syndrome (ACS group) who had undergone successful percutaneous coronary intervention (PCI), and 12 patients were also enrolled as controls (C group). Urinary and serum parameters were measured immediately before and after and 1 day after PCI.
    Results The ratio of U-L-FABP to U-creatinine (U-Cr) (U-L-FABP/U-Cr) in the ACS group was significantly higher than those in both the SAP and C groups before PCI. In addition, none of the patients in the SAP group showed contrast-induced nephropathy (CIN) based on the levels of serum (S)-Cr and U-L-FABP/U-Cr after PCI. Although none of the patients in the ACS group showed CIN according to S-Cr, the level of U-L-FABP/U-Cr was continuously high throughout the study period. Moreover, since there were significant differences in U-L-FABP/U-Cr, U-N-acetyl-β-D-glucosaminidase, S-uric acid and % medication with calcium channel blockers before PCI between the ACS and SAP groups, a multiple regression analysis was performed using these parameters. It showed that U-L-FABP/U-Cr was most closely associated with the classification of SAP and ACS (p<0.0001). The cut-off level for the greatest sensitivity and specificity for U-L-FABP for the diagnosis of ACS was 13.4 μg/g· Cr in all subjects (sensitivity 0.800, specificity 0.963).
    Conclusions To the best of our knowledge, this is the first report incicating that the measurement of U-L-FABP can be beneficial for in the diagnosis of ACS.
  • Yuko Tanaka, Makoto Nakajima, Teruyuki Hirano, Makoto Uchino
    2009 年 48 巻 19 号 p. 1739-1744
    発行日: 2009年
    公開日: 2009/10/01
    ジャーナル オープンアクセス
    Background and Purpose We investigated which factors influence pre-hospital delay after the onset of stroke and transient ischemic attack (TIA).
    Methods A total of 113 patients with ischemic stroke or TIA who were directly transported to the emergency room within 24 hours of onset were entered into the study. We analyzed factors relating to an early arrival at hospital (≤2 hours), and factors relating to an early emergency call (≤1 hour).
    Results The interval between symptom onset and arrival at hospital was within 2 hours in 75 (66%) patients. The interval between symptom onset and call to emergency was significantly related to arrival within 2 hours (p<0.001), whereas time (p=0.09) and distance (p=0.32) for transportation were not. The interval between onset and emergency call was within 1 hour in 68 patients (60%). The presence of a bystander (Odds ratio 3.68) and consciousness disturbance (Odds ratio 2.49) were independently related to an early emergency call.
    Conclusion An early emergency call is essential for the timely admission of stroke patients into a hospital. The presence of a bystander and consciousness disturbance are keys to an early emergency call.
CASE REPORTS
PICTURES IN CLINICAL MEDICINES
RETRACTION
feedback
Top